Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
<h4>Background</h4> <p>Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are...
Үндсэн зохиолчид: | Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
National Institute for Health Research
2016
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
-н: Thomas RE Barnes, зэрэг
Хэвлэсэн: (2016-04-01) -
Long-term antidepressant treatment for negative symptoms in schizophrenia: the actions study
-н: Barnes, T, зэрэг
Хэвлэсэн: (2017) -
Disclosing the potential impact of placebo controls in antidepressant trials
-н: Stephanie C. Chen, зэрэг
Хэвлэсэн: (2015-06-01) -
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
-н: Thomas RE Barnes, зэрэг
Хэвлэсэн: (2017-09-01) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
-н: Crawford, A, зэрэг
Хэвлэсэн: (2014)